T. Alan Hatton is the Ralph Landau Professor and Director of the David H. Koch School of Chemical Engineering Practice at the Massachusetts Institute of Technology. He obtained his BSc and MSc degrees in Chemical Engineering at the University of Natal, Durban, South Africa, and worked at the Council for Scientific and Industrial Research in Pretoria for three years before attending the University of Wisconsin, Madison, to obtain his PhD.
Current role
Co-founder & Scientific Advisor at Atalanta Therapeutics
Co-Founder & Scientific Advisor at Scribe Therapeutics
Co-Founder & Scientific Advisor at InterVenn Biosciences
Co-Founder & Scientific Advisor at Design Therapeutics
Co-Founder & Scientific Advisor at TwinStrand Biosciences